Anuj Mahindra
Scripps Health
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Anuj Mahindra as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 00:58 UTC. Open this list on ClinicalTrials.gov
- Ph3NCT02516423 · Ixazomib Citrate, Lenalidomide, Dexamethasone, and Zoledronic Acid or Zoledronic Acid Alone After Radiation Therapy in Treating Patients With Solitary Plasmacytoma of BoneAlliance for Clinical Trials in Oncology · terminated · Solitary Osseous Plasmacytoma · study chair
Grants
NIH projects from RePORTER, fetched 2026-11-12 00:58 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
NIH grants that fund their trials
These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.
- Alliance for Clinical Trials in Oncology Member Site CoreU10CA180821 · NCI · ALLIANCE NCTN FOUNDATION · PI Evanthia Galanis · fiscal years 2014 to 2026Named on NCT02516423
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 00:58 UTC. The ranking covers the 200 most relevant of 7 PubMed records, and a shared surname and initials can bring in a namesake. All 7 on PubMed
- Randomized Trial of Lenalidomide Versus Observation in Smoldering Multiple Myeloma.J Clin Oncol · 2020251 citationsRCR 9.8
- 146 citationsRCR 4.7
- 89 citationsRCR 2.7
- Risk of acute myeloid leukemia and myelodysplastic syndrome after autotransplants for lymphomas and plasma cell myeloma.Leuk Res · 201858 citationsRCR 2.0
- New cancers after autotransplantations for multiple myeloma.Biol Blood Marrow Transplant · 201541 citationsRCR 1.3
- Outcomes in patients with relapsed or refractory multiple myeloma in a phase I study of everolimus in combination with lenalidomide.Br J Haematol · 201434 citationsRCR 0.9
- Delayed hematopoietic recovery after auto-SCT in patients receiving arsenic trioxide-based therapy for acute promyelocytic leukemia: a multi-center analysis.Bone Marrow Transplant · 201510 citationsRCR 0.4